Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapse.
Krejci M, Scudla V, Tothova E, Schutzova M, Koza V, Adam Z, Krivanova A, Pour L, Buchler T, Sandecka V, Kralova D, Zahradova L, Vorlicek J, Mayer J, Hajek R. Krejci M, et al. Among authors: schutzova m. Clin Lymphoma Myeloma. 2009 Dec;9(6):436-42. doi: 10.3816/CLM.2009.n.086. Clin Lymphoma Myeloma. 2009. PMID: 19951883
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J. Krejcí M, et al. Among authors: schutzova m. Vnitr Lek. 2001 Sep;47 Suppl 1:40-7. Vnitr Lek. 2001. PMID: 11693062 Clinical Trial. Czech.
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
Adam Z, Pour L, Svobodník A, Scudla V, Salajka F, Vytrasová M, Bacovský J, Schützová M, Koza V, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Cahová S, Vránová M, Dostálová V, Kessler P, Walterová L, Meluzínová I, Seifertová N, Sláma O, Büchler T, Krejcí M, Bencíková V, Nykodýmová V, Dusek L, Hájek R; Czech Myeloma Group. Adam Z, et al. Among authors: schutzova m. Vnitr Lek. 2002 Mar;48(3):216-29. Vnitr Lek. 2002. PMID: 11968583 Clinical Trial. Czech.
[Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma].
Adam Z, Bednarík J, Neubauer J, Chaloupka R, Fojtík Z, Vanícek J, Pour L, Cermákova Z, Scudla V, Maisnar V, Straub J, Schützová M, Gregora E, Weinreb M, Stuchlíková K, Stanícek J, Hájek R, Krejcí M, Vorlícek J; Czech Myeloma Society. Adam Z, et al. Among authors: schutzova m. Vnitr Lek. 2006 Nov;52 Suppl 2:9, 11-31. Vnitr Lek. 2006. PMID: 18175427 Czech.
International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R. Tichý M, et al. Among authors: schutzova m. Neoplasma. 2006;53(6):492-4. Neoplasma. 2006. PMID: 17167717
Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P, Zemanova Z, Kuglik P, Michalova K, Tajtlova J, Kaisarova P, Oltova A, Filkova H, Holzerova M, Balcarkova J, Jarosova M, Rabasova J, Hruba M, Spicka I, Gregora E, Adam Z, Scudla V, Maisnar V, Schutzova M, Hajek R; Czech Myeloma Group. Nemec P, et al. Among authors: schutzova m. Leuk Lymphoma. 2012 May;53(5):920-7. doi: 10.3109/10428194.2011.634042. Epub 2011 Dec 13. Leuk Lymphoma. 2012. PMID: 22023516 Clinical Trial.
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
Penka M, Schwarz J, Pavlík T, Indrák K, Doubek M, Dulícek P, Pospísilová D, Kissová J, Jonásová A, Jelínková P, Hlusí A, Schutzová M, Cerná O, Brychtová Y, Nováková L, Korístek Z, Segethová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Walterová L, Bodzásová C, Dusek L. Penka M, et al. Among authors: schutzova m. Vnitr Lek. 2009 Nov;55(11):I-XII. Vnitr Lek. 2009. PMID: 20017445 Clinical Trial. Czech.
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
Penka M, Doubek M, Schwarz J, Pytlík R, Dulícek P, Kissová J, Hlusí A, Vozobulová V, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Schutzová M, Hadacová I, Hochová I, Voglová J, Siroký O, Belada D, Lhot'anová T, Bubeník B, Vránová M, Micaníková M, Dusek L. Penka M, et al. Among authors: schutzova m. Vnitr Lek. 2006 May;52(5):498-503. Vnitr Lek. 2006. PMID: 16771099 Czech.
27 results